Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

10,255 total articles

Esperion Presents New Data from CLEAR Outcomes and the CLEAR PATH Phase 2 Pediatric Study at the European Atherosclerosis Society Congress 2026

Esperion Presents New Data from CLEAR Outcomes and the CLEAR PATH Phase 2 Pediatric Study at the European Atherosclerosis Society Congress 2026

Esperion Therapeutics presented new data at the European Atherosclerosis Society Congress showing bempedoic acid's safety and efficacy in reducing LDL-C levels among children aged 6-17 with familial hypercholesterolemia, alongside a post hoc analysis highlighting factors linked to greater LDL-C reduction in statin-intolerant adults. These findings …

BioVie Announces Full Enrollment of the ADDRESS-LC Trial of Bezisterim for the Treatment of Neurological Symptoms Associated with Long COVID

BioVie Announces Full Enrollment of the ADDRESS-LC Trial of Bezisterim for the Treatment of Neurological Symptoms Associated with Long COVID

BioVie Inc. announced full enrollment of its Phase 2 ADDRESS-LC trial evaluating the investigational drug bezisterim for treating neurological symptoms associated with Long COVID. The trial is fully funded by a $13.13 million grant from the U.S. Department of War and targets cognitive impairment and fatigue in long COVID patients. Bezisterim is an …

Rani Therapeutics Holdings, Inc. Announces Pricing of $20.0 Million Registered Direct Offering of Class A Common Stock Priced At-The-Market Under Nasdaq Rules

Rani Therapeutics Holdings, Inc. Announces Pricing of $20.0 Million Registered Direct Offering of Class A Common Stock Priced At-The-Market Under Nasdaq Rules

Rani Therapeutics Holdings, Inc., a clinical-stage biotech company specializing in oral delivery of biologics, has priced a $20 million registered direct offering of Class A common stock at $1.07 per share. The offering includes pre-funded warrants and is led by a sovereign wealth fund, with proceeds aimed at supporting Rani's ongoing development a…

Microchip Launches 3.3 kV HV‑D3 mSiC® Power Modules to Enable Solid-State Transformers for AI Data Centers

Microchip Launches 3.3 kV HV‑D3 mSiC® Power Modules to Enable Solid-State Transformers for AI Data Centers

Microchip Technology has introduced 3.3 kV HV-D3 mSiC power modules designed to accelerate the adoption of solid-state transformers in AI hyperscale data centers and other high-voltage power uses. These modules incorporate silicon carbide MOSFETs and Schottky diodes to enable efficient power delivery from medium-voltage grids directly to server rac…

Glucotrack to Highlight Implantable Continuous Blood Glucose Monitoring Technology at the American Diabetes Association’s 2026 Scientific Sessions

Glucotrack to Highlight Implantable Continuous Blood Glucose Monitoring Technology at the American Diabetes Association’s 2026 Scientific Sessions

Glucotrack, Inc. will present its next-generation implantable continuous blood glucose monitoring (CBGM) system at the American Diabetes Association's 2026 Scientific Sessions. The technology offers multi-year implant longevity, direct blood measurements for improved accuracy, and eliminates the need for external wearables. The company has submitte…

Indonesia Energy Corporation Reports Rig Mobilization Complete for K-29 Well, the First of Two Planned Wells at Kruh Block in 2026

Indonesia Energy Corporation Reports Rig Mobilization Complete for K-29 Well, the First of Two Planned Wells at Kruh Block in 2026

Indonesia Energy Corporation Limited (INDO) announced the completion of rig mobilization at its K-29 well, part of the 2026 drilling campaign at the Kruh Block in Indonesia. Despite operational challenges in Indonesia's oil sector, IEC is progressing on schedule with drilling expected to start by late June 2026. The company views the current streng…

Vicor Corporation Revises Q2 2026 Revenue Guidance

Vicor Corporation Revises Q2 2026 Revenue Guidance

Vicor Corporation has revised its Q2 2026 revenue guidance upwards from $126 million to $142 million, driven by increasing product revenues and royalties following an all-inclusive license agreement with an OEM for its patented power system technologies, including Factorized Power and Vertical Power Delivery.

Nano Dimension Issues Letter to Shareholders

Nano Dimension Issues Letter to Shareholders

Nano Dimension Ltd. issued a letter to shareholders addressing an amended Schedule 13D filing by Murchinson Ltd., which seeks to gain control of Nano Dimension's board and cash assets. The Board opposes Murchinson's latest proxy contest efforts, emphasizing its ongoing strategic alternatives review aimed at maximizing shareholder value through disc…

Progyny, Inc. Announces Share Repurchase Program

Progyny, Inc. Announces Share Repurchase Program

Progyny, Inc., a leading global women's health and family building solutions company, announced that its Board of Directors has approved a share repurchase program to buy back up to $200 million of its common stock using available cash. The program aims to strategically support the stock price and return value to shareholders, with repurchases subj…

ASP Isotopes Implements Engineering Enhancements to Silicon-28 Enrichment Facility; Successfully Restarts First 18 Stages of Silicon-28 Enrichment Facility; Commercial Shipments of Enriched Silicon-28 Expected to Commence in Q3 2026

ASP Isotopes Implements Engineering Enhancements to Silicon-28 Enrichment Facility; Successfully Restarts First 18 Stages of Silicon-28 Enrichment Facility; Commercial Shipments of Enriched Silicon-28 Expected to Commence in Q3 2026

ASP Isotopes successfully restarts the initial 18 stages of its Silicon-28 enrichment facility following extensive engineering modifications addressing non-core components. The company aims to complete enhancements across remaining stages to commence commercial shipments of enriched Silicon-28 in Q3 2026 under contracts with U.S. customers focused …

zSpace and HealthForce Kentucky Bring Immersive Healthcare Training to 16 Counties and 28 Schools Across the Region

zSpace and HealthForce Kentucky Bring Immersive Healthcare Training to 16 Counties and 28 Schools Across the Region

zSpace, Inc., a pioneering provider of AR/VR educational technology, announced a partnership with HealthForce Kentucky to deploy 80 headset-free AR/VR devices across 16 counties and 28 schools, enhancing immersive healthcare training for students in nursing and allied health programs. The initiative includes a purpose-built simulation center and mo…

Gain Therapeutics Presents Positive Interim Data from Phase 1b Clinical Study of GT-02287 at 3rd International GBA1 Meeting 2026

Gain Therapeutics Presents Positive Interim Data from Phase 1b Clinical Study of GT-02287 at 3rd International GBA1 Meeting 2026

Gain Therapeutics presented positive interim data from its Phase 1b clinical study of GT-02287, demonstrating stable MDS-UPDRS scores and promising biomarker changes supporting disease-modifying potential in Parkinson's disease. Participants reported improvements in smell, taste, balance, and sleep, with differential benefits observed based on biom…

Gentherm Named a 2025 Supplier of the Year by General Motors

Gentherm Named a 2025 Supplier of the Year by General Motors

Gentherm, a leader in thermal management and pneumatic comfort technologies, was awarded the 2025 Supplier of the Year by General Motors at their annual event. This recognition highlights Gentherm's strong partnership, innovation, and high-quality delivery supporting GM's global operations and vehicle production. The company emphasizes continued co…

Pacira BioSciences Sets the Record Straight Regarding DOMA’s Misleading Statements About Pacira’s Intellectual Property Strategy

Pacira BioSciences Sets the Record Straight Regarding DOMA’s Misleading Statements About Pacira’s Intellectual Property Strategy

Pacira BioSciences issued a detailed statement addressing inaccurate claims made by activist investor DOMA Perpetual regarding the company's intellectual property strategy protecting its flagship non-opioid pain therapy, EXPAREL. The company highlighted the strength and recent reinforcements of its patent estate, ongoing litigation efforts against …

Cocrystal Pharma Announces Discovery of Pan-Viral Inhibitors Targeting Hantavirus, Bunyavirus and Influenza

Cocrystal Pharma Announces Discovery of Pan-Viral Inhibitors Targeting Hantavirus, Bunyavirus and Influenza

Cocrystal Pharma has discovered novel direct-acting antiviral compounds that target the viral replication complex enzyme L-protein, demonstrating potent activity against hantavirus, bunyavirus, and influenza. The company aims to develop broad-spectrum antiviral therapies leveraging its structure-based drug discovery platform, with initial data show…

Humacyte Announces Presentation at VASA Meeting of Research Highlighting Self-Repair of ATEV After Cannulation for Dialysis Access

Humacyte Announces Presentation at VASA Meeting of Research Highlighting Self-Repair of ATEV After Cannulation for Dialysis Access

Humacyte announced research presented at the VASA 2026 symposium demonstrating that its acellular tissue engineered vessel (ATEV) maintains long-term structural integrity and exhibits self-repair capabilities after repeated cannulations for dialysis access. The ATEVs showed smooth muscle cell repopulation, capillary ingrowth, collagen remodeling, a…

Lead Real Estate Introduces JINRYU HOTEL series, a Long-Stay Hospitality Concept for Japan’s Cultural Sites

Lead Real Estate Introduces JINRYU HOTEL series, a Long-Stay Hospitality Concept for Japan’s Cultural Sites

Lead Real Estate Co., Ltd, a Japanese developer listed on Nasdaq, announced the launch of the JINRYU HOTEL series, a boutique long-stay hotel brand designed to provide comfortable accommodations close to Japan's significant cultural and religious destinations. The first property, JINRYU HOTEL ISE, opened in March 2026 near the Outer Shrine of Ise J…